Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA ZYDUS LIFESCIENCES PLETHICO PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x -0.1 34.2 - View Chart
P/BV x 0.0 5.8 0.3% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 PLETHICO PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ZYDUS LIFESCIENCES
Mar-23
PLETHICO PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs254495 51.3%   
Low Rs31319 9.8%   
Sales per share (Unadj.) Rs604.6170.3 355.0%  
Earnings per share (Unadj.) Rs32.519.8 164.3%  
Cash flow per share (Unadj.) Rs51.326.9 190.7%  
Dividends per share (Unadj.) Rs06.00 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs473.7173.0 273.7%  
Shares outstanding (eoy) m34.071,012.20 3.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.22.4 9.9%   
Avg P/E ratio x4.420.6 21.3%  
P/CF ratio (eoy) x2.815.1 18.4%  
Price / Book Value ratio x0.32.4 12.8%  
Dividend payout %030.3 0.0%   
Avg Mkt Cap Rs m4,859412,144 1.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,54724,564 6.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,598172,374 11.9%  
Other income Rs m4194,746 8.8%   
Total revenues Rs m21,017177,120 11.9%   
Gross profit Rs m2,93829,677 9.9%  
Depreciation Rs m6427,227 8.9%   
Interest Rs m1,7471,299 134.5%   
Profit before tax Rs m96825,897 3.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1385,878 -2.4%   
Profit after tax Rs m1,10720,019 5.5%  
Gross profit margin %14.317.2 82.8%  
Effective tax rate %-14.322.7 -63.0%   
Net profit margin %5.411.6 46.3%  
BALANCE SHEET DATA
Current assets Rs m18,877100,082 18.9%   
Current liabilities Rs m11,89655,267 21.5%   
Net working cap to sales %33.926.0 130.3%  
Current ratio x1.61.8 87.6%  
Inventory Days Days7850 155.3%  
Debtors Days Days19894 211.5%  
Net fixed assets Rs m14,269144,776 9.9%   
Share capital Rs m3411,012 33.7%   
"Free" reserves Rs m15,798174,146 9.1%   
Net worth Rs m16,139175,158 9.2%   
Long term debt Rs m4,7060-   
Total assets Rs m33,146244,940 13.5%  
Interest coverage x1.620.9 7.4%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.7 88.3%   
Return on assets %8.68.7 98.9%  
Return on equity %6.911.4 60.0%  
Return on capital %13.015.5 83.9%  
Exports to sales %21.439.2 54.5%   
Imports to sales %15.211.9 127.7%   
Exports (fob) Rs m4,40267,577 6.5%   
Imports (cif) Rs m3,13620,544 15.3%   
Fx inflow Rs m4,40267,577 6.5%   
Fx outflow Rs m3,18420,544 15.5%   
Net fx Rs m1,21947,033 2.6%   
CASH FLOW
From Operations Rs m2,43726,888 9.1%  
From Investments Rs m-6,26511,712 -53.5%  
From Financial Activity Rs m2,490-44,004 -5.7%  
Net Cashflow Rs m24-5,338 -0.5%  

Share Holding

Indian Promoters % 57.8 75.0 77.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.4 18.0 107.7%  
FIIs % 2.7 5.0 54.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.3 25.0 168.9%  
Shareholders   16,430 306,495 5.4%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on PLETHICO PHARMA vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PLETHICO PHARMA vs Cadila Healthcare Share Price Performance

Period PLETHICO PHARMA Cadila Healthcare S&P BSE HEALTHCARE
1-Day -4.91% 0.57% 1.18%
1-Month -1.24% 7.77% -0.75%
1-Year -70.21% 107.52% 61.82%
3-Year CAGR -66.86% 32.30% 18.16%
5-Year CAGR -51.20% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the PLETHICO PHARMA share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of PLETHICO PHARMA hold a 57.8% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PLETHICO PHARMA and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, PLETHICO PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of PLETHICO PHARMA, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.